Skip to main content
. 2019 Dec 5;2019(12):CD011260. doi: 10.1002/14651858.CD011260.pub2

Jain 1997.

Methods Study design: open‐label, randomised trial
Setting: Tel Aviv, Israel
Study dates: not reported
Participants Sample size: 150 neonates
Dropouts/withdrawals: 45 neonates; 25 from group II and 20 from group III
Age: neonates
Sex: not reported
Inclusion criteria: healthy term, appropriate for date, newborns
Exclusion criteria: newborns with significant problems during the first week of life
Interventions Group IA (n = 25): III, at birth, 1.5 and 2.5 months
Group IB (n = 25): IOOO, at birth, 1.5, 2.5 and 3.5 months
Group II (n = 50): OOOO, at birth, 1.5, 2.5 and 3.5 months
Group III (n = 50): OOO at 1.5, 2.5 and 3.5 months
tOPV was obtained from Central Government Hospital supply. Each batch of the vaccine was tested for potency at NICD.
The IPV used was prepared at Merieux Institute, France. Each dose provides 40, 8 and 32 D antigen units against the three poliovirus types.
Outcomes
  • Seroconversion rates of neutralising antibodies to polio virus types 1, 2 and 3


Timing of assessment: 6 weeks, 10 weeks and 20 weeks
Follow‐up: 4.6 months
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "..all newborns who were randomly divided into three groups"
Quote: "The babies in the three groups after drop outs were comparable as regards their age and sex distribution, feeding pattern socioeconomic status and pre immunization antibody titers."
Comment: this description is insufficient to classify as high or low risk of bias
Allocation concealment (selection bias) Unclear risk Comment: not described
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Comment: no blinding but performance is not likely to be influenced by lack of blinding in terms of intervention or co‐interventions
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Comment: no blinding but objective outcome (antibody titres) is not likely to be influenced by lack of blinding
Incomplete outcome data (attrition bias) 
 All outcomes High risk Quote: "A total of 45 neonates who dropped out from the study belonged to Group II (25) and Group III (20)."
Selective reporting (reporting bias) Low risk Comment: no evidence of selecting reporting
Other bias Low risk Comment: no evidence of other bias
Conflict of interest Unclear risk Comment: not described